Biosero
San Diego, CA, USA
Biosero develops device-agnostic automation software, Green Button Go™ Automation Scheduling Software, for life science, pharmaceutical, and industrial manufacturing. The software enables complex, data-driven decisions and integrates hardware solutions from various OEMs to accelerate operations and increase productivity in laboratories, supporting drug discovery and development.
How We Help
Problem Statement
Biosero addresses the challenge of integrating and orchestrating diverse laboratory instruments and systems to eliminate bottlenecks in scientific discovery, thereby improving data integrity, reproducibility, and overall lab productivity for research and development.
Core Technology
automation software, Green Button Go™ Automation Scheduling Software
Key Differentiators
Hardware-agnostic Green Button Go software allowing flexible integration of diverse instruments; focus on end-to-end workflow orchestration; new assistive AI capabilities to accelerate research; over 20 years of experience as a trusted partner to top pharmaceutical and diagnostics companies globally.
Clinical Focus
Life science research and development, including drug development, diagnostics, multi-omics, tissue engineering, cell line development, cell & gene therapy, personalized medicine, precision medicine, and protein characterization. Specific support for areas like Hepatitis C, pain reduction, cancer, and COVID-19 diagnostics/research.
Target Customers
Life science research and development organizations, top pharmaceutical companies, and diagnostics companies globally.
Product Stage
Mature
Company Info
- Business Model
- B2B SaaS
- Founded
- 2003
- Total Funding
- 165,000,000
- Website
- www.biosero.com
Categories
Disease Areas
Technologies
MedStartr Index Score
?What do you think of Biosero?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.